Kenvue Chief Tech Officer Granted 79,407 RSUs
Kenvue Inc.
Subscribe to track KVUE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Kenvue Chief Tech Officer Granted 79,407 RSUs
Company: Kenvue Inc. (KVUE) Form: 4 | Filed: 2026-03-04 Significance: Low
Insider: Wondrasch Michael Title: Chief Tech & Data Officer | Relationship: Officer
Transaction: • Type: Grant (Restricted Stock Units) • Shares: 79,407 • Price: $0.00 • Value: $0 (Grant) • Owned After: 79,407
Key Insight: Routine executive compensation grant vesting over three years; not an open market purchase.
Market Context: Transaction represents <0.01% of outstanding shares for this $36.65B market cap company.
Comprehensive Analysis
SEC Filing Analysis: Kenvue Inc. (KVUE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Chief Tech & Data Officer receives standard RSU grant vesting through 2029.
- Market Impact: Neutral; routine compensation event with negligible dilution.
Company Information
| Field | Value |
|---|---|
| Company | Kenvue Inc. |
| Ticker Symbol | KVUE |
| CIK | 0001944048 |
| Market Cap | $36.65 Billion |
Insider Information
| Field | Value |
|---|---|
| Name | Wondrasch Michael |
| CIK | 0001776065 |
| Title/Position | Chief Tech & Data Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-02 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 79,407 |
| Price Per Share | $0.00 |
| Total Value | $0 (Grant) |
| Shares Owned After | 79,407 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Implied Value | ~$1.52 Million (Est. based on ~$19.13/share) |
| % of Market Cap | ~0.004% |
| Shares Transacted | 79,407 |
| % of Shares Outstanding | ~0.004% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a Large Cap company ($36.65B), this grant is immaterial to the broader market structure.
- Dilution Impact: The issuance of ~79k shares against 1.91 billion outstanding results in virtually zero dilution for existing shareholders.
- Vesting Schedule: The award vests in three equal installments on March 2 of 2027, 2028, and 2029, incentivizing long-term retention.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a standard compensation grant (Transaction Code 'A') rather than an open market purchase ('P') or sale ('S'). It reflects standard corporate governance rather than insider sentiment regarding stock valuation.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. While equity compensation aligns insider interests with shareholders, it does not signal a specific bullish conviction trade.
Additional Context
Transaction Notes
- Security: Restricted Stock Units (RSUs) convert 1-for-1 to Common Stock upon vesting.
- Timing: Annual grant cycle timing (March).
- Conditions: Vesting is subject to continued service through the applicable dates.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
